Correlation of Nerve Ultrasound, Electrophysiological and Clinical Findings in Chronic Inflammatory Demyelinating Polyneuropathy

Journal of Neuroimaging

Volumn 25, Issue 2, 2015, Pages 207-216

  Kerasnoudis, A ^a   Pitarokoili, K ^a   Behrendt, V ^a   Gold, R ^a   Yoon, M S ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Cross sectional area; Electrophysiology; Functional disability; Nerve ultrasound

Indexed keywords

ADULT; ARTICLE; BRACHIAL PLEXUS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; ECHOGRAPHY; ELECTRONEUROGRAPHY; FATIGUE SEVERITY SCALE; FEMALE; FUNCTIONAL DISEASE; HUMAN; MALE; MEDIAN NERVE; MIDDLE AGED; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; NERVE ULTRASOUND; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PERIPHERAL NERVE; PERONEUS NERVE; RADIAL NERVE; SURAL NERVE; TIBIAL NERVE; ULNAR NERVE; COMPARATIVE STUDY; ELECTRODIAGNOSIS; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; ELECTRODIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84924543632     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12079     Document Type: Article

References (45)

1. McLeod JG, Pollard JD, Macaskill P, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46:910-913.
2. Lunn MP, Manji H, Choudhary PP, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatr 1999;66:677-680.
3. Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011;7:507-517.
4. Lewis RA. Chronic inflammatory demyelinating polyneuropathy. Neurol Clin 2007; 25:71-87.
5. Koller H, Kieseier BC, Jander S, et al. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005;352:1343-1356.
6. Rajabally YA, Nicolas G, Pieret F, et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatr 2009;80:1364-1368.
7. Saperstein DS. Chronic acquired demyelinating polyneuropathies. Semin Neurol 2008;28:168-184.
8. Cornblath DR, Feasby TE, Hahn AF, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;5:617-618.
9. Zaidman CM, Al-Lozi M, Pestronk A. Peripheral nerve size in normal and patients with polyneuropathy: an ultrasound study. Muscle Nerve 2009;40:960-966.
10. Taniguchi N, Itoh K, Wang Y, et al. Sonographic detection of diffuse peripheral nerve hypertrophy in chronic inflammatory demyelinating polyneuropathy. J Clin Ultrasound 2000;28:488-491.
11. Matsuoka N, Kohriyama T, Ochi K, et al. Detection of cervical nerve root hypertrophy by ultrasonography in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 2004;219:15-21.
12. Kerasnoudis A. Nerve ultrasound in a case of chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve 2013;47:443-446.
13. Kerasnoudis A. Ultrasonographic findings in chronic inflammatory demyelinating polyneuropathy. Am J Phys Med Rehabil 2014;93(1):94.
14. Cartwright MS, Passmore LV, Yoon JS, et al. Cross-sectional area reference values for nerve ultrasonography. Muscle Nerve 2008;37:566-571.
15. Haun DW, Cho JC, Kettner NW. Normative cross-sectional area of the C5-C8 nerve roots using ultrasonography. Ultrasound Med Biol 2010;36:1422-1430.
16. Kerasnoudis A, Pitarokoili K. Ulnar nerve reference values for cross-sectional area, intranerve cross sectional area variability and side to side difference ratio. Rheumatol Int 2013. [Epub ahead of print].
17. Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Cross sectional area reference values for sonography of peripheral nerves and brachial plexus. Clin Neurophysiol 2013;124(9):1881-1888.
18. Kerasnoudis A, Yoon MS. The Role of Neuromuscular Ultrasound in the Diagnostic of Immune-Mediated Neuropathies. Advances in Neuropathy Research. New York: Nova Science Publishers;2013:119-133.
19. Padua L, Martinoli C, Pazzaglia C, et al. Intra- and internerve cross-sectional area variability: new ultrasound measures. Muscle Nerve 2012;45:730-733.
20. Kerasnoudis A, Klasing A, Behrendt V, et al. Intra- and internerve cross-sectional area variability: new ultrasound measures. Muscle Nerve 2013;47:146-147.
21. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society- first revision. Eur J Neurol 2010;17:356-363.
22. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 1991;14:1103-1109.
23. van Nes SI, Vanhoutte EK, van Doorn PA, et al. Rasch-built overall disability scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 2011;76:337-345.
24. van Nes SI, Vanhoutte EK, Faber CG, et al. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale. J Peripher Nerv Syst 2009;14:268-278.
25. Westblad ME, Forsberg A, Press R. Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disabil Rehabil 2009;31(9):720-725.
26. Erdmann PG, van Meeteren NL, Kalmijn S, et al. Functional health status of patients with chronic inflammatory neuropathies. J Peripher Nerv Syst 2005;10:181-189.
27. Ayrignac X, Viala K, Koutlidis RM, et al. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve 2013;48(5):727-732.
28. Rajabally YA, Wong SL. Chronic inflammatory pure sensory polyradiculoneuropathy: a rare CIDP variant with unusual electrophysiology. J Clin Neuromuscul Dis 2012;13:149-152.
29. Adachi Y, Sato N, Okamoto T, et al. Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. Neuroradiology 2011;53:3-11.
30. Bradley LJ, Wilhelm T, King RH, et al. Brachial plexus hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. Neuromuscul Disord 2006;16:126-131.
31. Misra UK, Kalita J, Yadav RK. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol 2007;58(2):100-105. Epub 2007 Jun 12.
32. Rajabally YA, Narasimhan M. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2011;18:293-299.
33. Harbo T, Andersen H, Jakobsen J. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2008;38:1036-1045.
34. Nagamatsu M, Terao S, Misu K, et al. Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatr 1999;66:727-733.
35. Madrid RE, Wisniewski HM. Axonal degeneration in demyelinating disorders. J Neurocytol 1977;6:103-117.
36. Hahn AF, Feasby TE, Steele A, et al. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage. Lab Invest 1988;59:115-125.
37. Hahn AF, Feasby TE, Lovgren D, et al. Adoptive transfer of experimental allergic neuritis in the immune suppressed host. Acta Neuropathol 1993;86:596-601.
38. Rajabally YA, Narasimhan M. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2010;297:11-14.
39. Viala K, Maisonobe T, Stojkovic T, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2010;15:50-56.
40. Beekman R, van den Berg LH, Franssen H, et al. Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology 2005;65:305-307.
41. Scheidl E, Böhm J, Simó M, et al. Ultrasonography of MADSAM neuropathy: focal nerve enlargements at sites of existing and resolved conduction blocks. Neuromuscul Disord 2012;22:627-631.
42. Kerasnoudis A. Ultrasonography of MADSAM neuropathy: focal nerve enlargements at sites of existing and resolved conduction blocks. Neuromuscul Disord 2012;22:1032.
43. Sghirlanzoni A, Solari A, Ciano C, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 2000;21:31-37.
44. Kerasnoudis A, Gold R, Klasing A, et al. Correlation of Morphological Changes in CIDP with the Disease Duration. 85. Congress of the German Neurological Society (DGN). 2012 Germany: Hamburg P555
45. Scheidl E, Böhm J, Farbaky Z, et al. Ultrasonography of ulnar neuropathy at the elbow: axonal involvement leads to greater nerve swelling than demyelinating nerve lesion. Clin Neurophysiol 2013;124:619-625.